Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

A hidden immune stress switch may be driving chemotherapy nerve pain and scientists have found a way to turn it off.

Please provide your email address to receive an email when new articles are posted on . Multiple diagnostic tools are necessary to assess diabetic peripheral neuropathy in patients. The choice of ...

Peripheral neuropathy is common in US adults and is associated with an increased risk of death, even in the absence of diabetes, researchers report today in the Annals of Internal Medicine. The ...

Each year in the United States there are more than 3 million cases of peripheral neuropathy, wherein nerves outside of the brain and spinal cord are damaged and cause pain and loss of feeling in the ...

Peripheral Neuritis Treatment market players – Pfizer, Depomed Inc, Novartis, Biogen Idec, GlaxoSmithKline Plc, Sanofi SA, Eli Lilly and Company, Bristol-Myers Squibb, among others represent the ...

Peripheral nerve impairments in older adults were tied to a higher risk of subsequent dementia, a study of longitudinal data showed. Combined sensory and motor impairments in the lower leg doubled the ...

Peripheral neuropathy is a common neurological disorder that can be associated with a wide range of conditions, including rheumatic disease. Although the association of the two disorders can be ...

Peripheral Neuritis Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The peripheral neuritis treatment market size is expected to see strong growth in the next ...

VALLEY COTTAGE, N.Y. – The business report depicts the present scenario of the worldwide Peripheral Neuritis Treatment Market in terms of value, production, and consumption. The growth outlook of the ...

Jolliffe, McLester and Sherman, 10 in discussing the prevalence of various types of nutritional polyneuropathy in diabetic and alcoholic patients, suggested that thiamine deficiency might account ...